Abstract 5775
Background
Determination of chemotherapy response in pancreatic cancer (PDAC) relies on imaging such as CT or MRI scan, where reliable results can be obtained not earlier than 12 weeks after treatment start. Herein we report, that determination of cell-free DNA (cfDNA) can improve treatment monitoring and may allow prediction of treatment response after administration of the first cycle of chemotherapy.
Methods
26 patients with advanced PDAC were treated with the FOLFIRINOX regime. Cell-free DNA (cfDNA) was determined from blood samples before treatment start and before each cycle (d1 and d15) for 3 months. In a subset, cfDNA was also determined during first FOLFIRINOX administration after infusion of oxaliplatin and irinotecan (8hrs). Tumor status was evaluated before treatment start and after 3 month by CT scan. cfDNA was extracted from at least 2 mL of plasma and ≥10ng total cfDNA was used for sequencing library preparation. Sequencing reads, obtained with a NextSeq500 (Illumina) were mapped to the reference genome (HG19) and read counted in 701 bins of autosomes, with an average size of 5.5Mb. After normalization and transformation into log2 ratios, Z-values were calculated versus a healthy reference group (133 cfDNA samples). Z-Scores of bins significantly different from the reference were summed to generate the CNI-score.
Results
The risk of patients (n = 11) with an elevated pre-therapeutic CNI-Score of > 200 for not responding to chemo was 82%. Patients with CNI-Score above the 95thpercentile of the reference population (CNI >24) after cycle 3, had a significantly higher risk to progress (80%), with a 73% accuracy of prediction (p = 0.03). The prediction of therapy failure was even better after 4 cycles with a 90% predictive value and an overall 83% accuracy (p = 0.02). In 13 patients CNI-score was determined after 8hrs of initiation therapy to assess a possible cytolytic tumor burst. Only patients showing a significant increase of CNI-scores, compared to pre-therapeutic values were responders (n = 2), one of three stable patients had a borderline burst, whereas all progressive patients (n = 8) did not show any sign of tumor burst.
Conclusions
Determination of cell free DNA represents a powerful tool to predict outcome very early during medical treatment of advanced PDAC.
Clinical trial identification
Legal entity responsible for the study
Alexander König.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract